Old Web
English
Sign In
Acemap
>
authorDetail
>
Julie Turbitt
Julie Turbitt
University of Aberdeen
Medicine
Cancer research
Oxaliplatin
Oncology
Internal medicine
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study
2020
Journal of Clinical Oncology
Anita Lavery
Leanne Stevenson
Damian T. McManus
Gemma E Logan
Steven M. Walker
Gera L. Jellema
Sandra Van Schaeybroeck
P S Virdee
Leena Elhussein
Julie Turbitt
Diane Colinson
Zofia Miedzybrodzka
Russell D. Petty
Paul Harkin
Richard D. Kennedy
Martin Eatock
Mark R. Middleton
Anne L. Thomas
Richard C. Turkington
Show All
Source
Cite
Save
Citations (0)
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed.
2020
Cancer Chemotherapy and Pharmacology
Madusha Meemanage
Lindsay C. Spender
Diane Collinson
Joanna Iannetta
Pranavi Challapalli
Julie Turbitt
C. Clark
Mark Baxter
Graeme I. Murray
Shaun V. Walsh
Zofia Miedzybrodzka
Russell D. Petty
Show All
Source
Cite
Save
Citations (0)
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: Why clinical trials have failed and how they could succeed
2020
Madusha Meemanage
Lindsay C. Spender
Diané Collinson
Joanna Iannetta
Pranavi Challapalli
Julie Turbitt
Caroline Clark
Mark A. Baxter
Graeme I. Murray
Shaun V. Walsh
Zofia Helena Miedzybrodzka
Russell D. Petty
Show All
Source
Cite
Save
Citations (0)
1